Adam Boruchov, MD
Hematology & Oncology · Hartford, CTNPI 1851362883
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $46,478 of the $54,646 with a category attached, or 85.1%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 88.8% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $26,577 and has fallen 98.5% since, to $400 in 2025. Among hematology & oncology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $975.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$49K
- AbbVie$4K
- Sanofi$542
- Seagen Inc.$394
- Mirati Therapeutics, Inc.$182
- Novartis$149
- plus $539 from 10 others
What the payments were for
- Consulting fees$4,3008%
- Speaking & faculty fees$46,47885%
- Travel & lodging$1,4983%
- Food & beverage$2,3094%
- Education$610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $48,513 |
| AbbVie | 3 | $4,328 |
| Sanofi | 7 | $542 |
| Seagen Inc. | 6 | $394 |
| Mirati Therapeutics, Inc. | 1 | $182 |
| Novartis | 2 | $149 |
| Geron Corporation | 2 | $146 |
| Johnson & Johnson | 1 | $113 |
| Gilead | 1 | $88 |
| Eisai Inc. | 2 | $52 |
| Jazz Pharmaceuticals Inc. | 2 | $41 |
| Bristol Myers Squibb | 1 | $24 |
| Bayer | 1 | $21 |
| Incyte Corporation | 1 | $20 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $17 |
| AVEO Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$54,646 in reported general payments places this provider in the 90th percentile of 163 hematology & oncology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Hartford
- Madhavi GorusuHartford$207K
- Shabnam RehmanHartford$25K
- Todd AlekshunHartford$22K
- Yelena PristyazhnyukHartford$9K
- Kin Wai HungHartford$7K
- Stephen FirsheinHartford$7K
- Paul DekkerHartford$6K
- Amer ZeidanNew Haven$807K
- Biree AndemariamFarmington$646K
- Paul WeinsteinStamford$288K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.